Where does Salvia BioElectronics B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Salvia BioElectronics B.V. ranks #25,124 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Salvia BioElectronics B.V. hold?

Salvia BioElectronics B.V. holds 11 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Salvia BioElectronics B.V.'s Innovation Score?

Salvia BioElectronics B.V. has an Innovation Score of 38.7 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Salvia BioElectronics B.V. focus on?

Salvia BioElectronics B.V.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 11 patents, ranking #336 of 1,943 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Salvia BioElectronics B.V.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Salvia BioElectronics B.V..

What does claim depth mean for Salvia BioElectronics B.V.'s patents?

Salvia BioElectronics B.V.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Salvia BioElectronics B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Salvia BioElectronics B.V.

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Salvia ranks #25,124 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.

#25,124
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 23.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R25124 · Foreign Corporation #25,124 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #25,124/49,997
PHOTO-FINISH Sabre Industries
CPC-NARROW A61N · 5 areas
INNOV-THIN 38.7/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Sabre Industries Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Salvia’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (22%) Velocity 8.3 pts (21%) Breadth 7.9 pts (20%) Claim depth 13.9 pts (36%)

Qualcomm Incorporated · highest

85
Bio-medical… · near

39
Data I/O · near

39
GE Oil & Gas ESP · near

39
Lexington Medical · near

39
Salvia BioElectronic… · this assignee

39
3D Lighting… · lowest

7

What this shows Salvia's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Salvia?

Each dot is one of Salvia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Salvia’s own 23.1 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Salvia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Salvia's grants concentrate

Salvia BioElectronics B.V. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2022. By volume, Salvia sits between Szegedi TUDOMÁNYEGYETEM and Saurer Technologies GmbH & Co. KG.

Salvia's three-year grant acceleration

Salvia BioElectronics B.V. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Szegedi TudomÁNye…

11
Sabre Industries

11
Sage Global Servi…

11
Saitama University

11
Sancilio &

11
Sandar Industries

11
Sassy Woof

11
Saurer & KG

11
Salvia Bioelectro… ◀

11

What this shows Salvia holds 11 patents at rank #25,219, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Salvia

By rank, the assignees closest to #25,219 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Salvia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Salvia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Salvia ranks #336 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Lexington Medical, Inc. 39 Data I/O Corporation 39 Bio-medical Engineering (HK) Limited 39 GE Oil & Gas ESP, Inc. 39

Salvia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Salvia BioElectronics B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	4	36.4%
2022	1	9.1%
2023	1	9.1%
2024	3	27.3%
2025partial year	2	18.2%

Which technologies does Salvia BioElectronics B.V. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

H04B - Transmission 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Salvia BioElectronics B.V.'s patent record in context - here's where to go next.

Salvia BioElectronics B.V.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #25,124 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Salvia BioElectronics B.V. against Szegedi TUDOMÁNYEGYETEM, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.